Study of the Efficacy and Safety of HS-10234 in Patients With Chronic Hepatitis B Virus Infection
Clinical trial NCT03903796 · COMPLETED
Trial details
- NCT number
- NCT03903796
- Sponsor
- Jiangsu Hansoh Pharmaceutical Co., Ltd.
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2018-08-16
- Primary completion
- 2020-05-31
- Enrollment
- 963
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.